AMS Course Descriptions
Healthcare Reform & Government Issues
ACO & Acute Care Reimbursement Trends
The rapid growth of Accountable Care Organizations (ACOs) shows no signs of slowing down. ACOs increase
provider collaboration and patient care coordination, which impacts products and supplies for all organizations
participating. Further, reimbursement policies tied to quality goals and cost savings mean ACOs are focused on
efficient, effective care. Join HIDA's Linda Rouse O'Neill, Vice President of Government Affairs and Elizabeth Hilla,
Senior Vice President and Executive Director of the HIDA Educational Foundation, to understand ACOs and how
they will continue to impact distributors.
The webinar answered:
• What is an ACO and what organizations can participate?
• What quality measures drive ACO decision-making?
• How do private sector ACOs differ from Medicare ACOs?
• How are ACOs changing the market and what trends should distributors expect?
Preparing for Round Two of Competitive Bidding
Whether you’ve won competitive bidding contracts or not, Medicare Part B is evolving. Round Two prices have been
announced and the Centers for Medicare and Medicaid Services (CMS) has started awarding contracts. CMS will
pay on average 45% less for durable medical equipment in Round 2 of the program, which is scheduled to expand
competitive bidding to 91 metropolitan statistical areas (MSAs) on July 1, 2013. How will you survive the Round 2
Listen to this recorded webinar to learn from industry expert Jeffrey Baird, Chairman of the Health Care Group at the
law firm Brown & Fortunato, about the following topics:
• Rights and obligations of a supplier under a contract;
• Sub-contract agreements;
• Potential new business models; and
• Best practices for surviving the new landscape.
Physician Sunshine Act final Regulation
Many distributors of drugs and devices requiring prescriptions have been stunned to discover that they are now
subject to sweeping new federal Physician Payment Sunshine Act reporting requirements. In a key definitional
change in the final regulation, CMS determined that distributors, wholesalers, repackagers, relabelers and kitters that
hold title to covered products will be considered an “applicable manufacturer” and required by federal law to report
any payments or transfers of value to physicians and teaching hospitals, including meals, consulting fees, gifts,
certain educational materials, and more. CMS will publish in the Internet the names of affected distributors, as well
as the payment amounts and the names of the physicians or hospitals to which payments were made. Failure to
report and inaccurate reporting will subject the distributor to civil monetary penalties.
With data collection required to start on August 1, 2013, and reporting required as of March 31, 2014, it is important
to understand the potential impact of this final rule on your business. Distributors and manufacturers alike will benefit
from this program where you will learn:
• How to determine if your company must report
• What products are covered
• What information must be reported to the government
• What payments and transfers of value must be reported
• What physicians and teaching hospitals are covered
• When civil money penalties apply
Best Practices for Vaccine Administration
In recent years, more vaccination programs have shifted to vaccines supplied in prefilled syringes to make their
vaccination process safer and more streamlined. Using vaccines in prefilled syringes ensures the least possible
chance of error while offering improved efficiency. Further research also indicates and quantifies that there are cost-
savings achieved by using prefilled syringes.
As healthcare providers begin pre-booking vaccines and preparing for the 2013-2014 flu season, check out this
webinar led by Dr. Litjen Tan, the Chief Strategy Officer of the Immunization Action Coalition. The webinar covered:
• Important safety initiatives that are aided by the use of prefilled syringes;
• New efficiencies gained by streamlining vaccine administration, and;
• Potential cost-savings available for providers.
Are You Ready for the Medical Device Excise Tax?
At a time when the industry is concerned about bringing costs down, the Medical Device tax, which will begin January
1, 2013, has providers, insurers and manufacturers concerned. What do distributors need to know about the tax
and how will it impact the products they provide? Join Rita Cavanagh, tax expert and partner with Latham & Watkins
to learn how the tax will impact the industry and how the IRS plans to treat kitting, retail exemptions and more.
This webinar answered:
• How the medical device tax defines a taxable medical device, retail exemption and kitting
• How businesses can best anticipate related 2013 FDA regulations that may impact the device tax
• What factors IRS agents may use in audits
Healthcare Consolidation Report
HIDA’s 2012 Healthcare Consolidation report provides insights into consolidation trends across markets. This
recorded webinar focused on several major healthcare consolidation trends discussed in this years’ report.
• Mergers and acquisitions
• Hospital-physician integration
• Accountable care organizations (ACOs)
• Integrated delivery networks (IDNs)
2012-2013 Economic Insights and Outlook
The U.S. economy is often described in complex economic jargon that can be rather difficult to distill. Multiple factors,
including unemployment, the housing market, inflation, and the current debt/deficit crisis, can be difficult to connect
for a complete picture of what the future holds. Join us for understandable insight on economic data and trends
relevant to businesses large and small.
This recorded webinar answered:
• How does our current financial situation compare to previous recessions?
• Where does the United States really stand relative to other global economies?
• What are the related business implications of the US economy's current direction?
Leaping into the Unknown: The Future of Healthcare Reform
The Supreme Court is expected to rule on healthcare reform by the end of June. No matter what its decision – to
strike down the law, to invalidate certain parts, or to leave it intact – questions will remain. In this interactive session,
get details on the decision and its likely significance for your company and your customers. HIDA’s government
affairs team assessed critical components of the healthcare reform law and determined what’s in and what’s out,
what’s unclear, and what’s next.
You’ll gain insights on:
• The future of accountable care organizations (ACOs)
• Implementation of the medical device tax
• New programs rewarding providers for positive outcomes, and penalizing them for infections and mistakes
• How providers are likely to respond
• How suppliers can help
UDI Proposed Rule: What Manufacturers and Distributors Need to Know
On Tuesday, July 3, 2012, The Food and Drug Administration (FDA) released its long-awaited proposed rule for
Unique Device Identification (UDI) requirements for medical devices. UDI requirements will permit the tracking of
certain medical devices throughout the supply chain, but some medical devices will be fully exempt from these
In this webinar, heard directly from senior FDA official Jay Crowley on what the FDA UDI rule means for our industry
in practical terms.
Discussion topics included:
• UDI effect on distributors, manufacturers, and providers
• Implementation timeline
• How to implement UDI
How Will ACOs Impact the Supply Chain?
As health reform implementation continues to transform the market landscape, how will accountable care
organizations (ACOs) impact organizations' use and purchasing habits for products and supplies? Join HIDA's Linda
Rouse O'Neill, Vice President of Government Affairs and Elizabeth Hilla, Senior Vice President and Executive
Director of the HIDA Educational Foundation, to understand what ACOs will look like and how they will impact
The webinar covered:
• What is an accountable care organization?
• How do policy regulations impact their quality and financ